Main Results from VALUE

Hypertension

Volumn , Issue , 2005, Pages 376-380

  Kjeldsen, Sverre E ^a,b   Julius, Stevo ^c   Weber, Michael A ^d   Stolt, Pelle ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748640506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50123-X     Document Type: Chapter

References (2)

1. Julius S, Kjeldsen SE, Weber MA, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomized trial. Lancet 2004, 363:2022-2031.
2. Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004, 363:2047-2049.